Why it was recalled
Presence of Foreign Tablets/Capsules
Product description
Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only. Manufactured by Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-026-02
Lot numbers, UPCs & expiration codes
Lot: CAL173502; Exp. 09/19
Where it was sold
Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0473-2018
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- Feb 13, 2018
- FDA report date
- Feb 28, 2018
- Quantity
- 1,439,000 oral capsules
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Nostrum Laboratories Inc
Original FDA data
Every field from FDA enforcement report D-0473-2018, exactly as published.
Show all FDA fields
- City
- Kansas City
- State
- MO
- Status
- Terminated
- Country
- United States
- Event ID
- 79210
- Address
- 1800 N Topping Ave
- Code information
- Lot: CAL173502; Exp. 09/19
- Postal code
- 64120-1228
- Report date
- Feb 28, 2018
- Product type
- Drugs
- Recall number
- D-0473-2018
- Classification
- Class III
- Recalling firm
- Nostrum Laboratories Inc
- Product quantity
- 1,439,000 oral capsules
- Termination date
- Dec 13, 2018
- Reason for recall
- Presence of Foreign Tablets/Capsules
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only. Manufactured by Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-026-02
- Distribution pattern
- Nationwide
- Recall initiation date
- Feb 13, 2018
- Initial firm notification
- Letter
- Center classification date
- Feb 20, 2018